CA983919A - Steroid compounds - Google Patents
Steroid compoundsInfo
- Publication number
- CA983919A CA983919A CA146,248A CA146248A CA983919A CA 983919 A CA983919 A CA 983919A CA 146248 A CA146248 A CA 146248A CA 983919 A CA983919 A CA 983919A
- Authority
- CA
- Canada
- Prior art keywords
- steroid compounds
- steroid
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Steroid compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3134971A GB1391443A (en) | 1971-07-05 | 1971-07-05 | Ester of betamethasone and its 9alpha-chloro analogue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA983919A true CA983919A (en) | 1976-02-17 |
Family
ID=10321802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA146,248A Expired CA983919A (en) | 1971-07-05 | 1972-07-04 | Steroid compounds |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5644079B1 (xx) |
| AR (2) | AR194120A1 (xx) |
| AU (1) | AU464251B2 (xx) |
| BE (1) | BE785812A (xx) |
| CA (1) | CA983919A (xx) |
| CH (1) | CH609065A5 (xx) |
| DE (1) | DE2232827A1 (xx) |
| DK (1) | DK131474B (xx) |
| FR (1) | FR2144761B1 (xx) |
| GB (1) | GB1391443A (xx) |
| IE (1) | IE36529B1 (xx) |
| IL (1) | IL39821A (xx) |
| NL (1) | NL169882C (xx) |
| NO (1) | NO137754C (xx) |
| PH (1) | PH13195A (xx) |
| SE (1) | SE385904B (xx) |
| ZA (1) | ZA724598B (xx) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8207151B2 (en) | 2008-05-28 | 2012-06-26 | Validus Biopharma Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5024427A (xx) * | 1973-01-03 | 1975-03-15 | ||
| DE2512915A1 (de) * | 1974-03-27 | 1975-10-09 | Plurichemie Anstalt | 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung |
| JPS6163976U (xx) * | 1984-10-01 | 1986-05-01 |
-
0
- BE BE785812D patent/BE785812A/xx not_active IP Right Cessation
-
1971
- 1971-07-05 GB GB3134971A patent/GB1391443A/en not_active Expired
-
1972
- 1972-07-04 JP JP6640472A patent/JPS5644079B1/ja active Pending
- 1972-07-04 IE IE939/72A patent/IE36529B1/xx unknown
- 1972-07-04 NL NLAANVRAGE7209345,A patent/NL169882C/xx not_active IP Right Cessation
- 1972-07-04 CA CA146,248A patent/CA983919A/en not_active Expired
- 1972-07-04 NO NO2406/72A patent/NO137754C/no unknown
- 1972-07-04 CH CH1003472A patent/CH609065A5/xx not_active IP Right Cessation
- 1972-07-04 IL IL39821A patent/IL39821A/xx unknown
- 1972-07-04 ZA ZA724598A patent/ZA724598B/xx unknown
- 1972-07-04 AU AU44205/72A patent/AU464251B2/en not_active Expired
- 1972-07-04 DE DE2232827A patent/DE2232827A1/de not_active Ceased
- 1972-07-04 SE SE7208817A patent/SE385904B/xx unknown
- 1972-07-04 DK DK331372AA patent/DK131474B/da unknown
- 1972-07-04 FR FR7224132A patent/FR2144761B1/fr not_active Expired
- 1972-07-04 AR AR242889A patent/AR194120A1/es active
- 1972-07-05 PH PH13687A patent/PH13195A/en unknown
-
1973
- 1973-05-21 AR AR248131A patent/AR194553A1/es active
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10857161B2 (en) | 2008-05-28 | 2020-12-08 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
| US8334279B2 (en) | 2008-05-28 | 2012-12-18 | Validus Genetics | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US8673887B2 (en) | 2008-05-28 | 2014-03-18 | Reveragen Biopharma, Inc | Non-hormonal steroid modulators of NF-kB for treatment of disease |
| US8207151B2 (en) | 2008-05-28 | 2012-06-26 | Validus Biopharma Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US9434758B2 (en) | 2008-05-28 | 2016-09-06 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US9649320B2 (en) | 2008-05-28 | 2017-05-16 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US11833159B2 (en) | 2008-05-28 | 2023-12-05 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
| US10206933B2 (en) | 2008-05-28 | 2019-02-19 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kB for treatment of disease |
| US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US10000525B2 (en) | 2010-04-05 | 2018-06-19 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11690853B2 (en) | 2015-06-29 | 2023-07-04 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κβ for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
| US11471471B2 (en) | 2019-03-07 | 2022-10-18 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| SE385904B (sv) | 1976-07-26 |
| CH609065A5 (en) | 1979-02-15 |
| IL39821A (en) | 1976-02-29 |
| AU464251B2 (en) | 1975-08-21 |
| AR194120A1 (es) | 1973-06-22 |
| NL169882C (nl) | 1982-09-01 |
| AU4420572A (en) | 1974-01-10 |
| NO137754C (no) | 1978-04-19 |
| BE785812A (fr) | 1973-01-04 |
| DE2232827A1 (de) | 1973-01-18 |
| NO137754B (no) | 1978-01-09 |
| IL39821A0 (en) | 1972-09-28 |
| DK131474B (da) | 1975-07-21 |
| IE36529L (en) | 1973-01-05 |
| NL7209345A (xx) | 1973-01-09 |
| IE36529B1 (en) | 1976-11-24 |
| FR2144761A1 (xx) | 1973-02-16 |
| ZA724598B (en) | 1973-03-28 |
| PH13195A (en) | 1980-01-18 |
| NL169882B (nl) | 1982-04-01 |
| GB1391443A (en) | 1975-04-23 |
| JPS5644079B1 (xx) | 1981-10-16 |
| FR2144761B1 (xx) | 1976-03-05 |
| AR194553A1 (es) | 1973-07-23 |
| DK131474C (xx) | 1975-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1003820A (en) | Steroid compounds | |
| CA1017336A (en) | Divinyl-diphenyl compounds | |
| AU459132B2 (en) | Etrachlorophthalide compounds | |
| AU466025B2 (en) | Aminohalopyridyloxy compounds | |
| CA1026346A (en) | Triazolyphosphorus compounds | |
| CA1006163A (en) | Arylaminopyridine compounds | |
| CA981269A (en) | 3-carbamoyl-4-phenyl-quinoline compounds | |
| AU466453B2 (en) | Triaszolothienodiazepine compounds | |
| CA977345A (en) | Perfluoroalkyl-phosphorus compounds | |
| AU464251B2 (en) | Steroid compounds | |
| CA955929A (en) | Steroids | |
| CA983946A (en) | Disilyl-containing compounds | |
| CA1019871A (en) | Arc- and track - resistant polyepoxide - polysiloxane compounds | |
| CA1001641A (en) | Polyhalobenzylic disulfooxonium compounds | |
| CA989389A (en) | Steroids | |
| CA869995A (en) | Steroidal compounds | |
| CA869996A (en) | Steroids | |
| CA879680A (en) | Cyclopropyl-substituted steroids | |
| CA873333A (en) | Steroid derivatives | |
| CA880332A (en) | Steroid analogs | |
| AU471594B2 (en) | Oxichromic compounds | |
| CA889310A (en) | Triazinylaminostilbene compounds | |
| AU451849B2 (en) | Sulfinyl-and sulfonylpyridine compounds | |
| CA861533A (en) | N-propargyl-pyridinium compounds | |
| CA866216A (en) | Gem-difluoramino compounds |